Bibliography
- DEBONO M, ABBOTT BJ, FUKUDA DS et al.: Synthesis ofnew analogs of echinocandin B by enzymatic deacyla-tion and chemical reacylation of the echinocandin B peptide: synthesis of the antifungal agent cilofungin (LY121019). j Antibiot. (1989) 42:389–397.
- SAWISTOWSKA-SCHRODER ET, KERRIDGE D, PERRY H:Echinocandin inhibition of 1,3-beta-D-glucan syn-thase from Candida albicans. FEBS Lett. (1984) 173:134–138.
- KURTZ MB, DOUGLAS C, MARRINAN J et al Increased antifungal activity of L-733,560, a water-soluble, semi-synthetic pneumocandin, is due to enhance inhibition of cell wall synthesis. Antimicrob. Agents Chemother. (1994) 38:2750–2757.
- •Describes properties of Merck's clinical candidate.
- HECTOR RF: Compounds active against the cell wall ofmedically important fungi. Clin. Microbiol. Rev. (1993) 6:1–21.
- MARTINEZ-SUAREZ JV, RODRIGUEZ-TUDELA JL: In vitroactivities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Can-dida albicans isolates. Antimicrob. Agents Chemother. (1996) 40:1277–1279.